ABSTRACT
INTRODUCTION
Obesity is a pathological condition in which excess body fat has accumulated to the extent that it may have an adverse effect on health leading to reduced life expectancy and/or increased health problems
(1).
The great similarity and homology between the genomes of rodents and humans make these animal models a major tool to study obesity (2) . Obesity is associated with an increased risk of nonalcoholic fatty liver disease (NAFLD) (3) . Steatosis, the hallmark feature of NAFLD, occurs when the rate of hepatic fatty acid uptake from plasma and de novo fatty acid synthesis is greater than the rate of fatty acid oxidation and export (4) . Reactive oxygen species (ROS) are generated as a result of normal metabolic processes in the cell, including the uncoupling of the electron transport chain in the mitochondria and the oxidation of excess NADPH by NADPH oxidase (5) . Accumulation of ROS in the body is highly correlated with obesity due to generation of these radicals from fat accumulation (6) . Xanthine oxidase (XO) is an enzyme that generates reactive oxygen species (7). It is a superoxide-producing enzyme found normally in the vascular endothelium (8) . Determination of total antioxidant capacity (TAC) is a tool in medical diagnosis and treatment of several diseases. In plasma, antioxidant molecules involved in free radical scavenging include endogenous (e.g. uric acid, albumin and circulating thiols) and exogenous (e.g. vitamins E and C) antioxidant molecules (15) . TAC considers the sum action of all the endogenous and exogenousderived antioxidants present in plasma and body fluids and provides an integrated parameter rather than the simple sum of measurable antioxidants (16) . It has been suggested that plasma TAC levels modified during oxidative stress conditions (15) . Porpoise oil is also known as dolphin oil, is pale yellow fatty oil extracted from porpoise adipose tissue by evaporation process. The tissues of porpoise contain combination of isovaleric acid and omega 3 polyunsaturated fatty acids (ω3 PUFAS)
(17).
Administration of porpoise oil was noted to act through the enhancement of lipoprotein secretion and to increase adiponectin production in experimental animals (17) .
AIM OF WORK:
The present work aimed to evaluate the possible mechanisms of obesity-induced oxidative stress and to determine the efficacy of porpoise oil on counteracting obesity-induced oxidative stress in rats.
MATERIALS & METHODS
The study was carried out on 75 female albino rats of 120 -150g body weight. During the study the animals were kept in wire mesh cages, room temperature was 22-24 ○ C, the animals were exposed to 12:12 hours light dark cycles, allowed free access to water and to either a control diet or high-fat diet. Experimental design: The studied animals were divided randomly into five groups, each comprise 15 rats: 1. Group I (control non obese): rats fed on normal caloric diet for 8 weeks. 2. Group II (control obese): rats received high fat diet for 8 weeks. 3. Group III (non obese with porpoise oil administration): non obese rats fed normal caloric diet with simultaneous administration of porpoise oil in a dose of 1ml/Kg. orally for 8 weeks. 4. Group IV (porpoise oil administered with obesity induction): rats fed high fat diet with simultaneous administration of porpoise oil in a dose of 1ml/Kg. orally for 8 weeks.
5.
Group V (porpoise oil administration after obesity induction): rats fed high fat diet for 6 weeks then administration of porpoise oil in a dose of 1ml/ Kg. orally for 2 weeks. Blood Sampling: After fasting for 12 hours the animals were anaesthetized by ether, and while the heart is still beating 3 ml of blood were collected via cardiac puncture on heparin, samples centrifuged and the plasma was separated, divided into aliquots and frozen at -70C o till used. All groups were subjected to plasma measurement of plasma xanthine oxidase activity Table (1) showed a significant increase of total body weight in group II compared to group I, group III, group IV and group V (P value<0.05). Also, there was significant increase in group II (Control obese) compared to group V (P value<0.05) Table ( 2) showed significant increase of visceral fat weight in control obese group compared to the other groups (P < 0.001).
RESULTS
Figure (1, 2) showed comparison between weight gain (g.) of the studied groups throughout the experimental study, starting from the initial weight at 0 week to weight at 8 weeks, each separated by one week interval.
ANOVA test shows significant differences between the studied groups (F values were 3.256, 3.147, 10.253, 7.253, 4.639, 10.253, 5.663, 9.263, and 7.362 respectively, P< 0.05). Table ( 3) showed significant increase of xanthine oxidase activity in group II compared to group I, group III, group IV and group V(P< 0.05).
Significant lower values were detected in group IV as compared to the other groups.
Total anti oxidant capacity showed significant increase in group III and group IV compared to group I, group II and Group V (P< 0.05) as illustrated in Table ( Group II: Control obese. Group III: Non obese rats with porpoise oil administration. Group IV: Porpoise oil administered with obesity induction. Group V: Porpoise oil administered after obesity induction. Group II: Control obese. Group III: Non obese rats with porpoise oil administration. Group IV: Porpoise oil administered with obesity induction. Group V: Porpoise oil administered after obesity induction. Group II: Control obese. Group III: Non obese rats with porpoise oil administration. Group IV: Porpoise oil administered with obesity induction. Group V: Porpoise oil administered after obesity induction. Group II: Control obese. Group III: Non obese rats with porpoise oil administration. Group IV: Porpoise oil administered with obesity induction. Group V: Porpoise oil administered after obesity induction. . This indicates increased proinflammatory cytokine production participating in assessed increments of MDA, LDL-C, TAG, TC, versus decrements of HDL-C and TAC as confirmed herein (56) . Nonetheless, the monitored hypolipidemic effect initiated by porpoise oil application to HFD-rats may involve both reduction of hepatic VLDL-TAG synthesis and secretion and enhancement of TAG clearance from chylomicrons and VLDL particles (38) . It may be related to the PUFA constituents of porpoise oil which could pertain a protective antiinflammatory role and indirectly an antioxidant role favoring physiological defense against obesityinduced HFD oxidative stress (57) . Accordingly, based on the monitored histopathological findings herein, it could be suggested that porpoise oil supplementation could prevent the development of fatty liver disease in obesity induced HFD rats (57) . It includes multifactorial mechanisms which may occur via the enhancement of lipoprotein secretion coinciding with the associated increased HDL-C and adiponectin production (37) . Furthermore, the cojoint validity of antioxidant role of porpoise oil relevant to its constitution of lipid lowering effects of ω-3 PUFAs beside its indirect action as antioxidant was evident (57) . It may reflect the role of the ω-3 PUFA that is one of the active constituents of porpoise oil which is known to be associated with decrease in transcription factors that control the expression of the enzyme responsible for TAG assembly within hepatocytes and responsible for fatty acid oxidation The interplay between the mutual role of ω-3PUFAs and adiponectin in porpoise oil reduction of plasma TAG increments assessed in obesity induced HFD-rats was verified by the associated increments of TAC and anti-inflammatory influence of porpoise oil verified by histopathological findings of hepatosteatosis
(17).
This could be interlinked to the histopathological finding implicating alleviation of hepatic steatosis in parallel to the monitored decreased plasma TAG, LDL-C, TC and increased HDL-C herein (59) . This outcome of both antioxidant and antiinflammatory co-linked potency of porpoise oil proved to be beneficial as a natural remedy to obesity induced immune dysregulation and immuneinflammatory disposition
This response to porpoise oil impact potentiating production and activity of adiponectin was verified herein by the co-joint change monitored in both XO and H 2 O 2 levels in parallel to TAC and MDA with suppression of hyperlipidemia (17) . Moreover, it may be relevant to the other active constituents of porpoise oil including both forms of TAG and phospholipids as well as appreciable amounts of the iso-C5:0valeric acid which can be accommodated in porpoise phospholipids (60) . Hence, the phospholipid components are composed of hydrophobic fatty acids and the hydrophilic moiety choline, ethanolamine, serine or inositol, it is also possible that ω-3PUFAs (in porpoise oil) could enhance the lipidlowering activity of phosphatidylcholine in the liver of obese rats, in addition to reducing NADPH oxidase and inducible nitric oxide synthase (iNOS) activities (61) . This represents the anti-inflammatory effects of ω-3PUFAs besides its role in metabolic correction by reducing blood lipids and blood glucose which may altogether contribute to the antioxidative properties as well (62) . It was reported that serum adiponectin levels were significantly increased by porpoise oil feeding to obese rats, having protective effects against fatty liver diseases through enhancement of lipoprotein synthesis and secretion in rats (63). Furthermore, the present study reflected the beneficial effect of porpoise oil supplement prior to HFD induction of obesity which decelerated free radical generation and progression of OS induced hyperlipidemia influencing immunoinflammatory mechanisms (64) . Porpoise oil in HFD-rats, by lowering the assessed incremental levels of TC, H 2 O 2 , XO and MDA, it could reduce the increased production of hydroxyl radicals which was noted to extract an electron from polyunsaturated lipids generating high oxygen producing lipid peroxyl radicals and LOOH 
